Currently Viewing:
The Academy of Managed Care Pharmacy (AMCP) 2018
Specialty Drug Pipeline Review Focuses on Competition, Cancer Drugs
April 24, 2018
Dr Robert Navarro Discusses Progress in Shift to Value-Based Care
April 24, 2018
Brian Litten Outlines How Medication Therapy Management Can Address Opioid Misuse
April 24, 2018
Who Decides What Value Looks Like in US Healthcare?
April 24, 2018
Currently Reading
Dr Brandon Newman Discusses Payer, Academic Medical Center Collaboration
April 25, 2018
Migraines in the US Are More Than Just a Pain Problem
April 25, 2018
Market Access Teams Face New Challenges in Pharma
April 25, 2018
Cardiologist Talks About Value of Monoclonal Antibody Evolocumab
April 26, 2018
Dr Somali Burgess on the Role of Patient-Reported Outcomes in Managed Care Pharmacy
April 26, 2018
Dr Tina Joseph Discusses Collaborative Practice Agreements Between Pharmacists, Physicians
April 26, 2018
Navigating the Rocky Waters to Value-Based Healthcare
April 26, 2018
Hemophilia: Treatment Landscape, Costs, and Disease Management
April 26, 2018
Dr Aimee Tharaldson on Recently Approved Specialty Drugs, Upcoming Approvals to Watch
May 05, 2018
Dr Calvin Knowlton Outlines Benefits Seen From Enhanced Medication Therapy Management
May 06, 2018
The Rise of Orphan Drugs for Rare Diseases
May 07, 2018
Dr Robert Navarro Foresees Unintended Consequences From Shift to Value-Based Care
May 12, 2018
Dr Kimberly Lenz: Identifying Patients Most at Risk For Substance Abuse
May 13, 2018
Brian Litten Outlines Challenges With Adopting Medication Therapy Management Services
May 17, 2018
Dr Tina Joseph Outlines Pharmacists' Role in Managing Chronic Diseases, Value-Based Care Models
May 19, 2018
Dr Calvin Knowlton on Innovative Practices in Enhanced Medication Therapy Management
May 20, 2018
Dr Ashley Pappas Discusses Collaboration Between Academic Centers and Payers
May 24, 2018
Dr Robert Navarro on Pharma Implementing Value, Best Practices for Value-Based Contracts
May 25, 2018
Drug Approvals That Dr Aimee Tharaldson Is Keeping an Eye on for 2019
May 27, 2018
Dr Kimberly Lenz on Implementing, Enforcing Appropriate Opioid Prescribing
June 04, 2018

Dr Brandon Newman Discusses Payer, Academic Medical Center Collaboration

Brandon Newman, PharmD, MMHC, CSP, program director, specialty pharmacy, Vanderbilt University Medical Center, explains the benefits of collaboration between payers and academic centers and how this collaboration, in turn, benefits patients.


Brandon Newman, PharmD, MMHC, CSP, program director, specialty pharmacy, Vanderbilt University Medical Center, explains the benefits of collaboration between payers and academic centers and how this collaboration, in turn, benefits patients.

Transcript

What are the benefits of collaboration between payers and academic medical centers?

I think 1 thing, from my perspective in working for a dispensing pharmacy that’s based out of an academic medical center, is that first and foremost, we have to be able to dispense these drugs to these patients so we can follow the patients really closely. So, 1 big challenge with us is payer lockout. I think that if we can collaborate with a payer to be able to become part of that network to be able to fill for those patients, we can follow them closely, and, by following them closely, we can monitor their long-term clinical outcomes. I think that’s really where we can work closely with payers to make sure that patients are responding appropriately to these high-cost meds.

What are different examples of opportunities payers and academic centers can collaborate on?

I think 1 example of a way payers and manufacturers can collaborate is by a payer allowing a health system specialty pharmacy into their network and then by giving thresholds for the specialty pharmacy to be able to meet. Really, what that does is it holds the bar high so that patients are getting really good quality care, and then by providing this data back to the payer, they can use it for their analytics and benchmarking and be able to determine that patients are getting the best benefits and that the specialty pharmacy is doing a great job.

How does this collaboration, in turn, benefit patients?

What we found from patients that use our specialty pharmacy is that the satisfaction surveys are really good. We follow these patients really closely, make sure they’re doing well and not having any side effects, and managing those medications. The patients are really happy about that. We’re able to provide very personalized service. The patients meet the pharmacist face to face in clinic, they get phone calls as a follow-up from the pharmacist, and they’re very happy with it. We have very good satisfaction surveys that go to show that patients are happy with our service.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up